These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 9831326)

  • 21. KW-4679, an antiallergic drug, inhibits the production of inflammatory lipids in human polymorphonuclear leukocytes and guinea pig eosinophils.
    Ikemura T; Manabe H; Sasaki Y; Ishii H; Onuma K; Miki I; Kase H; Sato S; Kitamura S; Ohmori K
    Int Arch Allergy Immunol; 1996 May; 110(1):57-63. PubMed ID: 8645979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
    Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
    Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eosinophil chemotaxis induced by several biologically active substances and the effects of apafant on it in vitro.
    Nabe T; Yamamura H; Kohno S
    Arzneimittelforschung; 1997 Oct; 47(10):1112-6. PubMed ID: 9368704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropeptides modulate human eosinophil chemotaxis.
    Numao T; Agrawal DK
    J Immunol; 1992 Nov; 149(10):3309-15. PubMed ID: 1385521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory effects of formoterol on platelet-activating factor induced eosinophil chemotaxis and degranulation.
    Eda R; Sugiyama H; Hopp RJ; Okada C; Bewtra AK; Townley RG
    Int Arch Allergy Immunol; 1993; 102(4):391-8. PubMed ID: 8241801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IgA-induced eosinophil degranulation.
    Abu-Ghazaleh RI; Fujisawa T; Mestecky J; Kyle RA; Gleich GJ
    J Immunol; 1989 Apr; 142(7):2393-400. PubMed ID: 2926137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of salmeterol on human eosinophils is both stimulus- and response-dependent.
    Ezeamuzie CI; al-Hage M; Nwankwoala RN
    Int J Immunopharmacol; 1997 Aug; 19(8):421-30. PubMed ID: 9568547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification on receptors for leukotriene B4 expressed on guinea-pig peritoneal eosinophils.
    Sehmi R; Rossi AG; Kay AB; Cromwell O
    Immunology; 1992 Sep; 77(1):129-35. PubMed ID: 1328044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of interleukin-5 in enhanced migration of eosinophils from airways of immunized guinea-pigs.
    Coëffier E; Joseph D; Vargaftig BB
    Br J Pharmacol; 1994 Nov; 113(3):749-56. PubMed ID: 7858864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional properties of guinea pig eosinophil leukotriene B4 receptor.
    Ng CF; Sun FF; Taylor BM; Wolin MS; Wong PY
    J Immunol; 1991 Nov; 147(9):3096-103. PubMed ID: 1655904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of terfenadine on human eosinophil and neutrophil chemotactic response and generation of superoxide.
    Eda R; Townley RG; Hopp RJ
    Ann Allergy; 1994 Aug; 73(2):154-60. PubMed ID: 8067599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD11b/CD18 (Mac-1) is required for degranulation of human eosinophils induced by human recombinant granulocyte-macrophage colony-stimulating factor and platelet-activating factor.
    Horie S; Kita H
    J Immunol; 1994 Jun; 152(11):5457-67. PubMed ID: 7514638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of human eosinophil chemotaxis in vitro by the anti-allergic agent emedastine difumarate.
    el-Shazly AE; Masuyama K; Samejima Y; Eura M; Ishikawa T
    Immunopharmacol Immunotoxicol; 1996 Nov; 18(4):587-95. PubMed ID: 8933171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modification of eosinophil function by suplatast tosilate (IPD), a novel anti-allergic drug.
    Suwaki T; Agrawal DK; Townley RG
    Int Immunopharmacol; 2001 Nov; 1(12):2163-71. PubMed ID: 11710545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
    Liu L; Zuurbier AE; Mul FP; Verhoeven AJ; Lutter R; Knol EF; Roos D
    J Immunol; 1998 Sep; 161(6):3064-70. PubMed ID: 9743372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effects of ketotifen on eotaxin-dependent activation of eosinophils: consequences for allergic eye diseases.
    Woerly G; Loiseau S; Loyens M; Schoch C; Capron M
    Allergy; 2003 May; 58(5):397-406. PubMed ID: 12752326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transmigration of eosinophils through basement membrane components in vitro: synergistic effects of platelet-activating factor and eosinophil-active cytokines.
    Okada S; Kita H; George TJ; Gleich GJ; Leiferman KM
    Am J Respir Cell Mol Biol; 1997 Apr; 16(4):455-63. PubMed ID: 9115757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of anti-asthmatic drugs on human eosinophil chemotaxis].
    Numao T; Fukuda T; Akutsu I; Makino S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Jan; 29(1):65-71. PubMed ID: 1645817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of leukotriene C4 and B4 release by human eosinophils with the new 5-lipoxygenase inhibitor 6-hydroxy-2(4-sulfamoylbenzylamino)-4,5,7-trimethylbenzothiazo le hydrochloride.
    Fukuda T; Numao T; Akutsu I; Toda M; Motojima S; Makino S
    Arzneimittelforschung; 1995 Sep; 45(9):1002-4. PubMed ID: 7488299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of PAF, FMLP and opsonized zymosan on the release of ECP, elastase and superoxide from human granulocytes.
    Turner NC; Wood LJ; Foster M; Gueremy T
    Eur Respir J; 1994 May; 7(5):934-40. PubMed ID: 8050551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.